Zobrazeno 1 - 10
of 71
pro vyhledávání: '"C. P. Girish Kumar"'
Autor:
Anuradha Rajamanickam, Nathella Pavan Kumar, Arul Nancy Pandiarajan, Nandhini Selvaraj, Saravanan Munisankar, Rachel Mariam Renji, Vijayalakshmi Venkatramani, Manoj Murhekar, Jeromie W. V. Thangaraj, Muthusamy Santhosh Kumar, C. P. Girish Kumar, Tarun Bhatnagar, Manickam Ponnaiah, R. Sabarinathan, V. Saravanakumar, Subash Babu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Monocytes are thought to play an important role in host defence and pathogenesis of COVID-19. However, a comprehensive examination of monocyte numbers and function has not been performed longitudinally in acute and convalescent COVID-19. We
Externí odkaz:
https://doaj.org/article/33680c86d3764ec7a1763ce879b0908e
Autor:
Aditya Sharma, Ulzii-Orishikh Luvsansharav, Prabasaj Paul, Joseph D. Lutgring, Douglas R. Call, Sylvia Omulo, Kayla Laserson, Rafael Araos, Jose M. Munita, Jennifer Verani, Fahmida Chowdhury, Syeda Mah-E Muneer, Andres Espinosa-Bode, Brooke Ramay, Celia Cordon-Rosales, C. P. Girish Kumar, Tarun Bhatnagar, Neil Gupta, Benjamin Park, Rachel M. Smith
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Antimicrobial resistance is a global health emergency. Persons colonized with multidrug-resistant organisms (MDROs) are at risk for developing subsequent multidrug-resistant infections, as colonization represents an important prec
Externí odkaz:
https://doaj.org/article/aa9e534b8d7741a8912be6c3ad9b2d88
Autor:
Jeromie Wesley Vivian Thangaraj, Muthusamy Santhosh Kumar, C. P. Girish Kumar, Pragya Yadav, D. Sudha Rani, T. Karunakaran, Manoj Murhekar
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
India witnessed a very strong second wave of coronavirus disease 2019 (COVID-19) during March and June 2021. Newly emerging variants of concern can escape immunity and cause reinfection. We tested newly diagnosed COVID-19 cases during the second wave
Externí odkaz:
https://doaj.org/article/427127edbded44bdb764863bc1205ad9
Autor:
Sidhartha Giri, C. P. Girish Kumar, Shainey Alokit Khakha, Mamta Chawla-Sarkar, Varanasi Gopalkrishna, Shobha D. Chitambar, Pratima Ray, S. Venkatasubramanian, Biswa Jyoti Borkakoty, Subarna Roy, Jyothi Bhat, Bhagirathi Dwibedi, Pradeep Das, Vijayachari Paluru, Sasirekha Ramani, Sudhir Babji, Rashmi Arora, Sanjay M. Mehendale, Mohan D. Gupte, Gagandeep Kang, National Rotavirus Surveillance Network investigators
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background From 2016, the Government of India introduced the oral rotavirus vaccine into the national immunization schedule. Currently, two indigenously developed vaccines (ROTAVAC, Bharat Biotech; ROTASIIL, Serum Institute of India) are inc
Externí odkaz:
https://doaj.org/article/361cc55827974227acbad73e5ea0f5de
Autor:
Sidhartha Giri, Nayana P. Nair, Ann Mathew, B. Manohar, Anna Simon, Tejinder Singh, S. Suresh Kumar, M. A. Mathew, Sudhir Babji, Rashmi Arora, C. P. Girish Kumar, S. Venkatasubramanian, Sanjay Mehendale, Mohan D. Gupte, Gagandeep Kang
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background In 2016, the Government of India introduced the oral rotavirus vaccine (ROTAVAC, Bharat Biotech, India) in 4 states of India as part of the Universal Immunization Programme, and expanded to 5 more states in 2017. We report four ye
Externí odkaz:
https://doaj.org/article/65d8d561ec1741b2bd759e39dd712cf9
Autor:
Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Nandhini Selvaraj, Rachel Mariam Renji, Saravanan Munisankar, Jeromie Wesley Vivian Thangaraj, Santhosh Kumar Muthusamy, C. P. Girish Kumar, Tarun Bhatnagar, Manickam Ponnaiah, Sabarinathan Ramasamy, Saravanakumar Velusamy, Manoj Vasant Murhekar, Subash Babu
Publikováno v:
Viruses, Vol 14, Iss 3, p 511 (2022)
Background: Examination of CD4+ T cell responses during the natural course of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection offers useful information for the improvement of vaccination strategies against this virus and the pr
Externí odkaz:
https://doaj.org/article/6d5bae73cf5c43d19ba1a07effe08df3
Autor:
Muthusamy Santhosh Kumar, C Govindhasamy, T Karunakaran, Pavan Kumar, R. Sabarinathan, Uday Mohan, A Jeyakumar, Sailaja Bitragunta, P. K. Sahoo, Chander Prakash Yadav, T Daniel Rajasekar, A. Suresh, Suman Sundar Mohanty, Dominic Augustine, Nivedita Gupta, G S Toteja, P Kamaraj, Vivek Sagar, C. P. Girish Kumar, Bhagirathi Dwibedi, Subarna Roy, Pradip V Barde, Deepali Savargaonkar, Provash Chandra Sadhukhan, P V M Lakshmi, Shanta Dutta, Sanjay Mehendale, Chandra Mauli Mishra, J.W. Banerjee John, Annamma Jose, R. Sivakumar, Gagandeep Singh Grover, Shivendra Kumar Singh, Rajesh Kumar, Manoj V Murhekar, Babasaheb V. Tandale, Ramesh Reddy Allam, Suman Kanungo, Siraj Ahmed Khan, Roshan Kamal Topno
Publikováno v:
The Lancet Infectious Diseases. 21:868-875
Summary Background Diphtheria is re-emerging as a public health problem in several Indian states. Most diphtheria cases are among children older than 5 years. In this study, we aimed to estimate age-specific immunity against diphtheria in children ag
Autor:
Nathella Pavan, Kumar, V V, Banurekha, C P Girish, Kumar, Arul, Nancy, Chandrasekaran, Padmapriyadarsini, Sakila, Shankar, Luke Elizabeth, Hanna, Manoj, Murhekar, K R Uma, Devi, Subash, Babu
Publikováno v:
Journal of Travel Medicine. 29
Background Covaxin/BBV152 is one of the most widely used vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and one of the few vaccines used extensively in low- and middle-income countries (LMIC). Methods We inves
Autor:
Shanta Dutta, Harpreet Singh Pawar, Giridhara R Babu, V. Saravanakumar, Kanwar Narain, Ezhilarasan Ilayaperumal, Sanjay Zodpey, Babu Jagjeevan, Swarup Sarkar, Srikanta Kanungo, Tekumalla Ramarao, Vijay K. Shukla, Jaya Singh Kshatri, Ashrafjit S. Chahal, Aparup Das, Balram Bhargava, Hari Bhan Singh, R Anusha, Chethana Rangaraju, Dinesh Kumar Baradwaj, Smita Asthana, Ravindra Mohan Pandey, Prashant Singh, T Sivakumar, Krithikaa Sekar, Dasarathi Das, Arlappa Nimmathota, Sampada Dipak Bangar, Kamran Zaman, M. Sunil Kumar, Sujeet Kumar Singh, R. Sabarinathan, Naman Shah, Hirawati Deval, Arshad Kalliath, K Kalaiyarasi, Kamalesh Sarkar, Muthusamy Santhosh Kumar, Seema Sahay, Rajiv Yadav, Sanket Kulkarni, Alok Kumar, Vishal Chopra, Rajeev Gupta, C. P. Girish Kumar, Rajeev K. Singh, Kiran Rade, Kangjam Rekha Devi, Shripad A. Patil, Alka Turuk, T Karunakaran, Jyothi Bhat, Annamma Jose, J P Muliyil, Kushal Singh Rathore, Shalini Singh, Tanzin Dikid, Nivethitha N Krishnan, A.R. Nirmala, Hemalatha Rajkumar, G G J Naga Lakshmi, Shashi Kant, Avula Laxmaiah, Major Madhukar, Pradeep Das, Amarendra Mahapatra, Manoj V Murhekar, Gaurav Raj Dwivedi, Pushpendra Singh, Jeromie Wesley Vivian Thangaraj, Sarang Dhatrak, Tanu Anand, K Kiran, Gurudayal S Toteja, Ankit Viramgami, Rakesh Balachandar, Ganta Venkata Prasad, Sauvik Dasgupta, Samiran Panda, Ashok Kumar Pandey, Sanghamitra Pati, Suman Sundar Mohanty, Dantuluri Sheethal Varma, S. Muhammad Salim Khan, Vimith Cheruvathoor Wilson, Mariya Amin Qurieshi, Anshuman Chaudhury, Sriram Selvaraju, Alok Kumar Deb, Avi Kumar Bansal, Tarun Bhatnagar, D C S Reddy, Himanshu Chauhan, Rushikesh Andhalkar, Ashwini Yadav, Inaamul Haq, Falguni Debnath, Rajni Kant, Josephine Pradhan, Anindya Mitra, Somashekar Narasimhaiah, Ramesh Kumar Sangwan, Raman R. Gangakhedkar, Aakash Shrivastava, VG Vinoth Kumar, Ramesh Chandra Jha, Aby Robinson, K. Nagbhushanam
Publikováno v:
The Lancet Global Health
The Lancet. Global Health
The Lancet. Global Health
BACKGROUND: The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in India, done in May-June, 2020, among adults aged 18 years or older from 21 states, found a SARS-CoV-2 IgG antibody seroprevalence of 0·73% (95%
Autor:
S Kumaravel, Namasivayam Selvarajan, C. P. Girish Kumar, Priyadarshini Dorairaj, Samarasimha Reddy N, Varunkumar Thiyagarajan, J Muthu Kumaran, M Kulandaivel, Balasubramanian Sundaram, Aswitha Shenoy, Rajamani Guruswamy, Raghul Maniam, B Hemanth Kumar, Senthilnathan Subramanian, P Ramasubramaniam
Publikováno v:
The Indian Journal of Pediatrics. 88:124-130
High burden of rotavirus associated diarrhea has been documented among Indian children. The phased introduction of an indigenous rotavirus vaccine ‘ROTAVAC’ in India's national immunization programme began in 2017. Phase-III trial showed the vacc